Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate vs Lidocaine for Myofascial Pain Dysfunction Syndrome
NCT06595017Phase 2Not yet recruiting
- Sponsor
- Misr University for Science and Technology
- Start
- Oct 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of magnesium sulfate in myofascial pain syndrome (MPS), sponsored by Misr University for Science and Technology. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT06595017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06595017.